Ken Griffin Revolution Medicines, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 10,700 shares of RVMD stock, worth $618,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,700

Previous 14,300 25.17%

Holding current value

$618,995

Previous $554,000 12.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $4.72 Million - $6.13 Million	-127,905 Reduced 31.28%	280,937 $12.7 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $5.4 Million - $7.29 Million	-179,246 Reduced 30.48%	408,842 $15.9 Million
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $8.39 Million - $10.6 Million	-315,941 Reduced 34.95%	588,088 $19 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $12.1 Million - $22.4 Million	657,571 Added 266.81%	904,029 $25.9 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $6.2 Million - $8.64 Million	246,458 New	246,458 $6.82 Million
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $3.66 Million - $5.31 Million	-176,416 Reduced 99.82%	323 $6,000
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $2.7 Million - $3.9 Million	152,687 Added 634.82%	176,739 $4.21 Million
Q3 2022 Nov 14, 2022	SELL	$17.46 - $26.0 $3.02 Million - $4.5 Million	-173,008 Reduced 87.79%	24,052 $474,000
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $1.89 Million - $3.54 Million	130,258 Added 194.99%	197,060 $3.84 Million
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $5.14 Million - $7.84 Million	-297,103 Reduced 81.64%	66,802 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $6.59 Million - $9.12 Million	270,483 Added 289.53%	363,905 $9.16 Million
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $2.5 Million - $3.49 Million	-104,339 Reduced 52.76%	93,422 $2.57 Million
Q2 2021 Aug 16, 2021	SELL	$29.0 - $47.44 $26.7 Million - $43.6 Million	-919,431 Reduced 82.3%	197,761 $6.28 Million
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $4.56 Million - $6.67 Million	-122,484 Reduced 9.88%	1,117,192 $51.3 Million
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $26.1 Million - $39.4 Million	865,211 Added 231.05%	1,239,676 $49.1 Million
Q3 2020 Nov 16, 2020	SELL	$22.61 - $34.8 $1.07 Million - $1.65 Million	-47,471 Reduced 11.25%	374,465 $13 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $1.44 Million - $2.88 Million	73,294 Added 21.02%	421,936 $13.3 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $6.97 Million - $11.9 Million	348,642 New	348,642 $7.64 Million

Others Institutions Holding RVMD

# of Institutions

267

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $5.07B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account